Hong Kong’s Drug Safety Program Under Question Following Allopurinol Deaths
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - Hong Kong is re-examining its pharmaceutical safety system after five people died from using infected versions of the gout drug allopurinol sold under the brand name Purinol by local pharmaceutical company Europharm